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of the Placebo Response
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Introduction
Occasionally, we are asked why patients undergoing a surgical
procedure cannot act as their own controls in a clinical study.
After all, prior to their procedure they exhibit a certain level of
pain and disability, and after the procedure there is a change;
often they have less pain and less disability. Is this not the result
of the procedure? The short answer to the question whether the
change is due to the procedure is simply, “maybe, maybe not.”
While it is true that the change occurred when the surgical pro-
cedure was given, the change is not necessarily the effect of the
surgical procedure itself. How can this be? The answer is that the
treatment response is about more than the surgical procedure. It
is about the cultural meaning of treatment: the way the surgery is
proposed by the surgeon, the ceremony around the procedure,
and the expectations of the surgeon and patient. These all have
an impact on outcome. Does this seem improbable to you? Wel-
come to the strange world of the placebo response.
It is difficult to identify exactly when placebo (Latin,
“I shall please”) first entered into medical practice. In 1785,
A New Medical Dictionary described placebo as “a common-
place method or medicine.”1 Thomas Jefferson, in his letter to
Dr Caspar Wistar in 1807, wrote, “One of the most successful
physicians I have ever known, has assured me, that he used
more bread pills, drops of colored water, powders of hickory
ashes, than of all other medicines put together.”2 A few years
prior, a British physician, John Haygarth, reported using a pla-
cebo treatment in a small crossover study of 5 patients. He
compared expensive metal rods (Perkins tractors) intended to
draw out disease, to wooden lookalike tractors. Four of 5
patients with “rheumatism” reported improved pain with either
rod.3 Drug studies administering placebos to patients with
angina followed in the early 20th century and found no benefit
of various drugs compared to placebo.4,5 At about the same
time, a placebo controlled study tested the popular idea from
earlier observations that vaccines were successful in preventing
the common cold. The study reported no difference between
the effectiveness of placebo and vaccine, concluding,
One of the most significant aspects of this study is the great reduc-
tion in the number of colds which the members of the control
groups reported during the experimental period. In fact these
results were as good as many of those reported in uncontrolled
studies which recommended the use of cold vaccines.6(p1172)
Placebo Response Versus Placebo Effect
Over time, we have come to recognize that there is not one
response to a placebo but many.7 We refer to the sum total of
patients’ responses to the administration of the placebo as the
placebo response. This includes some proportion of the
response that likely would have occurred in the absence of any
treatment such as the natural history of a disease, regression to
the mean, and response bias. Natural history denotes the
change, up and down, of the symptoms over time. Regression
to the mean refers to a statistical principle that if a variable is
extreme on its first measurement, it will tend to be closer to the
average on its second measurement, and vice versa. Response
bias is the tendency for study participants to provide answers
they believe investigators want to hear. The placebo effect is
the proportion of improvement or worsening that remains after
controlling for all the other incidental effects (Figure 1).8
Improbable Responses of Placebos
Below is a sample of some bizarre results from placebo
administration.
 Four sugar pills are more effective than 2 pills. One
study reported that a placebo allotted 4 times/day
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resulted in greater duodenal ulcer healing compared
with placebo administered 2 times/day.9
 The route of placebo administration is important. In the
case of migraine pain, placebo injection of saline was
more effective than oral placebo in relieving migraine
pain10 and in reducing hypertension.11
 Factors contributing to the placebo response can be com-
bined. In patients with irritable bowel syndrome, pla-
cebo acupuncture alone resulted in greater symptom
improvement than waitlist controls; and placebo acu-
puncture augmented by practitioner warmth, attention,
and confidence resulted in the greatest symptom
improvement of all.12
 How the placebo is presented affects results. Flashy
brand name packaging, for example, enhanced the effect
of aspirin and placebo sugar pills compared with bland,
neutral boxes in women with headaches.13
 Placebo (sham) surgery is effective in a host of condi-
tions. It has been shown to reduce pain and disability in
trials of vertebroplasty.14,15 Furthermore, sham surgery
was effective in treating knee osteoarthritis16 and degen-
erative meniscus tears17 as well as pain conditions,
obesity, reflux disease, endoscopic procedures, and per-
cutaneous procedures.18 Finally, sham surgery has been
shown to reduce symptoms in Parkinson’s disease in
part due to its effect on the release of dopamine.19
 People’s expectations moderate health benefits. In one
study a group of female room attendants were told that
the work they do (cleaning hotel rooms) is good exer-
cise and satisfies the Surgeon General’s recommenda-
tions for an active lifestyle. Subjects in the control
group were not given this information. Though beha-
vior did not change, 4 weeks after the intervention, the
informed group perceived themselves to be getting
significantly more exercise than before. And, com-
pared with the control group, they showed a decrease
in weight, blood pressure, body fat, waist-to-hip ratio,
and body mass index.20
 Another example of the power of patient expectation is a
study comparing the effectiveness of analgesic drugs
administered by a computer-controlled infusion pump
without the patient’s knowledge versus open administra-
tion of the drug by a clinician and described to the
patient as a pain-relieving intervention. The effects of
the blinded administration via the infusion pump was
markedly reduced compared with open administration
by the clinician.21
 Clinicians’ expectations also influence the placebo
response. In an elegant study of clinician expectation,
3 different agents were given to patients having wisdom
teeth extraction: saline injection, fentanyl, or naloxone.
Patients were split into 2 groups. In the first group, the
clinicians giving the treatment, though blinded to the
treatment, were told rightly that they would be giving
1 of the 3 treatments. In the second group, the clinicians
were deceived and told that they would only be giving
placebo or naloxone when in reality they also were
administering 1 of the 3 treatments. The clinicians
believed that no one in the second group would receive
the pain-relieving fentanyl. Even though a similar pro-
portion of patients in each group received fentanyl, the
first group experienced significantly less pain.22
Contribution of Effects Following Surgical
Intervention
When evaluating a surgical procedure in a clinical trial, 3 dif-
ferent choices for a control group exist: no intervention, active
agent (eg, nonsurgical control or another surgical method), or a
placebo control. The selection of the control group helps inves-
tigators identify the magnitude of effect that is additive from
the various aspects contributing to the overall effect (Figure 2).
Comparison of surgery versus no intervention allows infer-
ences about the efficacy of the surgical procedure ruling out
contributions from the natural history. Comparison of surgery
to another treatment (surgical or nonsurgical intervention)
allows interferences of the added effect of the treatment of
interest, its equivalence, and even its comparative safety. Add-
ing a placebo group enables investigators to distinguish the true
effect of a surgical procedure itself from the natural history and
the other components of the placebo response.
Summary
 A treatment response is about more than the surgical
procedure. It is about the cultural meaning of treatment;
the way the surgery is proposed by the surgeon, the
ceremony around the procedure, and the expectations
Figure 1. Placebo response.
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of the surgeon and patient. These all have an impact on
outcome.
 The placebo response is the total response to the admin-
istration of a placebo. This includes any response as a
result of the natural history of a disease, regression to the
mean, and response bias. The placebo effect is the pro-
portion of improvement or worsening that remains after
controlling for all the other incidental effects.
 Choosing a certain control group in a clinical trial helps
investigators identify the source of the effect of a surgi-
cal procedure.
 Whether the use of placebo surgery is ethical in clinical
trial research is a subject of great debate, and beyond the
scope of this article. However, clinical researchers need
to think carefully about inferences drawn from trials that
have no placebo intervention.
 The placebo response magnifies the importance of a
comparison group in any study designed to evaluate the
effectiveness or efficacy of a specific treatment. The
results of a single-arm study (ie, case series) should
rarely ever be reported as supporting the effectiveness
of a specific surgical intervention.
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